Latest News and Press Releases

DURHAM, N.C., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Codetta Bio™, a leading innovator in multi-omic solutions that integrate ultrasensitive protein quantitation with simultaneous analysis of nucleic...

RetinalGenix signs agreement to hire M. Cory Zwerling as its chief financial officer and interim chief operating officer, effective January 1, 2026

arcoris bio raises CHF 6.3 million to advance the development & commercialization of its breakthrough biomarker detection platform MUSE®.

Boston, Oct. 31, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “The Chinese Market for DNA Sequencing” is projected to grow from $1.2 billion in 2025 to $3.1 billion by...

The company aims to uncover molecular and cellular signatures associated with disease onset, progression, and risk, often before clinical symptoms appear.

RetinalGenix Technologies and RGEN Announce Strategic Collaboration to Advance Early Detection of Neurodegenerative, Systemic, and Retinal Diseases.

RetinalGenix Technologies Advances Home and Remote Monitoring Patent Portfolio, Positioning for the Future of Ocular and Systemic Disease Care

Biognosys launches metabolomics/lipidomics services with biocrates, expanding multiomics CRO offerings for drug discovery and clinical research.

Cost-Efficient Methodology Aims To Reduce Reliance On Expensive Diagnostic Procedures Such As MRI, CT Scans, PET Scans, and Echocardiograms

APOLLO BEACH, Fla., May 05, 2025 (GLOBE NEWSWIRE) -- RetinalGenix Technologies, Inc. (OTCQB:RTGN) (“RetinalGenix” or the “Company”), announced today a new laboratory lease agreement with life...